Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels
- PMID: 18593906
- DOI: 10.1158/0008-5472.CAN-08-0634
Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels
Abstract
The serine/threonine kinase Pim is known to promote cell cycle progression and to inhibit apoptosis leading to tumorigenesis. However, the precise mechanisms remain unclear. We show, herein, that all the Pim family members (Pim1, Pim2, and Pim3) bind to and directly phosphorylate the cyclin-dependent kinase inhibitor p27(Kip1) at threonine-157 and threonine-198 residues in cells and in vitro. The Pim-mediated phosphorylation induced p27(Kip1) binding to 14-3-3 protein, resulting in its nuclear export and proteasome-dependent degradation. Ectopic expression of Pim kinases overcome the G(1) arrest mediated by wild-type p27(Kip1) but not by phosphorylation-resistant T157A-p27(Kip1) or T198A-p27(Kip1). In addition to the posttranslational regulations, p27(Kip1) promoter assay revealed that Pim kinases also had the ability to suppress p27(Kip1) transcription. Pim-mediated phosphorylation and inactivation of forkhead transcription factors, FoxO1a and FoxO3a, was involved in the transcriptional repression of the p27(Kip1) gene. In contrast, inhibition of Pim signaling by expressing the dominant-negative form of Pim1 increased nuclear p27(Kip1) level and attenuated cell proliferation. Because the CDK inhibitor p27(Kip1) plays a crucial role in tumor suppression by inhibiting abnormal cell cycle progression, Pim kinases promote cell cycle progression and tumorigenesis by down-regulating p27(Kip1) expression at both transcriptional and posttranslational levels.
Similar articles
-
A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression.EMBO J. 2002 Jul 1;21(13):3390-401. doi: 10.1093/emboj/cdf343. EMBO J. 2002. PMID: 12093740 Free PMC article.
-
The inhibition of activated hepatic stellate cells proliferation by arctigenin through G0/G1 phase cell cycle arrest: persistent p27(Kip1) induction by interfering with PI3K/Akt/FOXO3a signaling pathway.Eur J Pharmacol. 2015 Jan 15;747:71-87. doi: 10.1016/j.ejphar.2014.11.040. Epub 2014 Dec 10. Eur J Pharmacol. 2015. PMID: 25498792
-
p27(Kip1) signaling: Transcriptional and post-translational regulation.Int J Biochem Cell Biol. 2015 Nov;68:9-14. doi: 10.1016/j.biocel.2015.08.005. Epub 2015 Aug 14. Int J Biochem Cell Biol. 2015. PMID: 26279144 Review.
-
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer.Nat Med. 2002 Oct;8(10):1136-44. doi: 10.1038/nm762. Epub 2002 Sep 16. Nat Med. 2002. PMID: 12244303
-
Targeting p27Kip1 protein: its relevance in the therapy of human cancer.Expert Opin Ther Targets. 2011 Jun;15(6):677-93. doi: 10.1517/14728222.2011.561318. Epub 2011 Feb 28. Expert Opin Ther Targets. 2011. PMID: 21355788 Review.
Cited by
-
Pim-1 kinase is a positive feedback regulator of the senescent lung fibroblast inflammatory secretome.Am J Physiol Lung Cell Mol Physiol. 2022 Dec 1;323(6):L685-L697. doi: 10.1152/ajplung.00023.2022. Epub 2022 Oct 12. Am J Physiol Lung Cell Mol Physiol. 2022. PMID: 36223640 Free PMC article.
-
Phosphorylation of the androgen receptor by PIM1 in hormone refractory prostate cancer.Oncogene. 2013 Aug 22;32(34):3992-4000. doi: 10.1038/onc.2012.412. Epub 2012 Sep 17. Oncogene. 2013. PMID: 22986532 Free PMC article.
-
Leflunomide Synergizes with Gemcitabine in Growth Inhibition of PC Cells and Impairs c-Myc Signaling through PIM Kinase Targeting.Mol Ther Oncolytics. 2019 May 17;14:149-158. doi: 10.1016/j.omto.2019.04.006. eCollection 2019 Sep 27. Mol Ther Oncolytics. 2019. PMID: 31211245 Free PMC article.
-
Hispidulin suppresses cell growth and metastasis by targeting PIM1 through JAK2/STAT3 signaling in colorectal cancer.Cancer Sci. 2018 May;109(5):1369-1381. doi: 10.1111/cas.13575. Epub 2018 Apr 17. Cancer Sci. 2018. Retraction in: Cancer Sci. 2020 Jun;111(6):2196. doi: 10.1111/cas.14487. PMID: 29575334 Free PMC article. Retracted.
-
REDD1 is a determinant of the sensitivity of renal cell carcinoma cells to autophagy inhibition that can be therapeutically exploited by targeting PIM activity.Cancer Lett. 2025 Mar 31;613:217496. doi: 10.1016/j.canlet.2025.217496. Epub 2025 Jan 30. Cancer Lett. 2025. PMID: 39892703
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous